The upregulation of glutaminase 1 (GLS1) has been observed in preclinical mouse models of NASH, as well as in liver biopsies obtained from patients diagnosed with clinical NASH. The gene discussed is GLS; the disease is metabolic dysfunction-associated steatohepatitis.